PURPOSE: High-frequency oscillatory ventilation (HFOV) is thought to protect the lungs of acute respiratory distress syndrome (ARDS) patients. The performance and mechanical characteristics of high-frequency oscillatory ventilators, especially with regard to delivering appropriate tidal volume (V(T)) to compromised lungs, might affect the outcome of patients. We evaluated the performance of two such ventilators using a model lung with a position sensor. METHODS: We tested the Metran R100 and SensorMedics 3100B. V(T) was measured using the model lung with the compliance set at 20 or 50 ml/cmH₂O and the resistance at 0 or 20 cmH₂O/l/s. Oscillator frequency was set at 5, 7, and 9 Hz, and amplitude was set at 25%, 50%, 75%, and 100% (100% being maximum amplitude available at each setting configuration). RESULTS: At each model lung setting, R100 delivered greater V(T) at 5 Hz. V(T) differences between the ventilators decreased as frequency increased and were negligible at 9 Hz. At each model lung setting and frequency, as amplitude increased from 25% to 100%, V(T) increased proportionally more with R100. With an I:E ratio of 1:1, 3100B delivered greater V(T) than with 1:2. CONCLUSION: Because it is able to deliver comparably greater V(T), R100 may be a better choice for HFOV in critical ARDS patients. Better proportionality may be a result of more effective amplitude titration for adjusting PaCO₂ during oscillation.
PURPOSE: High-frequency oscillatory ventilation (HFOV) is thought to protect the lungs of acute respiratory distress syndrome (ARDS) patients. The performance and mechanical characteristics of high-frequency oscillatory ventilators, especially with regard to delivering appropriate tidal volume (V(T)) to compromised lungs, might affect the outcome of patients. We evaluated the performance of two such ventilators using a model lung with a position sensor. METHODS: We tested the Metran R100 and SensorMedics 3100B. V(T) was measured using the model lung with the compliance set at 20 or 50 ml/cmH₂O and the resistance at 0 or 20 cmH₂O/l/s. Oscillator frequency was set at 5, 7, and 9 Hz, and amplitude was set at 25%, 50%, 75%, and 100% (100% being maximum amplitude available at each setting configuration). RESULTS: At each model lung setting, R100 delivered greater V(T) at 5 Hz. V(T) differences between the ventilators decreased as frequency increased and were negligible at 9 Hz. At each model lung setting and frequency, as amplitude increased from 25% to 100%, V(T) increased proportionally more with R100. With an I:E ratio of 1:1, 3100B delivered greater V(T) than with 1:2. CONCLUSION: Because it is able to deliver comparably greater V(T), R100 may be a better choice for HFOV in critical ARDSpatients. Better proportionality may be a result of more effective amplitude titration for adjusting PaCO₂ during oscillation.
Authors: S Mehta; S E Lapinsky; D C Hallett; D Merker; R J Groll; A B Cooper; R J MacDonald; T E Stewart Journal: Crit Care Med Date: 2001-07 Impact factor: 7.598
Authors: M B Amato; C S Barbas; D M Medeiros; R B Magaldi; G P Schettino; G Lorenzi-Filho; R A Kairalla; D Deheinzelin; C Munoz; R Oliveira; T Y Takagaki; C R Carvalho Journal: N Engl J Med Date: 1998-02-05 Impact factor: 91.245
Authors: V M Ranieri; P M Suter; C Tortorella; R De Tullio; J M Dayer; A Brienza; F Bruno; A S Slutsky Journal: JAMA Date: 1999-07-07 Impact factor: 56.272
Authors: Stephen Derdak; Sangeeta Mehta; Thomas E Stewart; Terry Smith; Mark Rogers; Timothy G Buchman; Brian Carlin; Stuart Lowson; John Granton Journal: Am J Respir Crit Care Med Date: 2002-09-15 Impact factor: 21.405
Authors: Sherry E Courtney; David J Durand; Jeanette M Asselin; Mark L Hudak; Judy L Aschner; Craig T Shoemaker Journal: N Engl J Med Date: 2002-08-29 Impact factor: 91.245
Authors: Sangeeta Mehta; John Granton; Rod J MacDonald; Dennis Bowman; Andrea Matte-Martyn; Thomas Bachman; Terry Smith; Thomas E Stewart Journal: Chest Date: 2004-08 Impact factor: 9.410